Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Association between Transfusion Status and Overall Survival in Patients with Myelodysplastic Syndromes: A Systematic Literature Review and Meta-Analysis Apr 2016 Acta Haematol myelodysplastic syndromes (MDS)
Clonal hematopoiesis in acquired aplastic anemia Apr 2016 Blood aplastic anemia
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes Apr 2016 Anemia myelodysplastic syndromes (MDS)
Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia Apr 2016 Int J Hematol aplastic anemia
Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes? Apr 2016 Haematologica myelodysplastic syndromes (MDS)
Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models. Mar 2016 Expert Rev Hematol myelodysplastic syndromes (MDS)
The Efficacy of Current Prognostic Models in Predicting Outcome of Patients with Myelodysplastic Syndromes at the Time of Hypomethylating Agent Failure Mar 2016 Haematologica myelodysplastic syndromes (MDS)
Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS-CAN prospective study Mar 2016 Br J Haematol myelodysplastic syndromes (MDS)
Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes Mar 2016 Cancer myelodysplastic syndromes (MDS)
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial Mar 2016 Lancet Oncol myelodysplastic syndromes (MDS)